{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:21:35Z","timestamp":1779211295611,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cysticfibrosisjournal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jcf.2020.05.002","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T11:36:35Z","timestamp":1590838595000},"page":"546-552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease"],"prefix":"10.1016","volume":"19","author":[{"given":"Wikrom","family":"Karnsakul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7555-453X","authenticated-orcid":false,"given":"Paul","family":"Wasuwanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thammasin","family":"Ingviya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Vasilescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1880-0850","authenticated-orcid":false,"given":"Peter J.","family":"Mogayzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen B.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcf.2020.05.002_bib0001","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMe020070","article-title":"What Is Cystic Fibrosis?","volume":"347","author":"Knowles","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jcf.2020.05.002_bib0002","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg3849","article-title":"Cystic fibrosis genetics: from molecular understanding to clinical application","volume":"16","author":"Cutting","year":"2015","journal-title":"Nat Rev Genet"},{"issue":"4","key":"10.1016\/j.jcf.2020.05.002_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212779","article-title":"The emerging burden of liver disease in cystic fibrosis patients: A UK nationwide study. Strnad P, ed","volume":"14","author":"Toledano","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jcf.2020.05.002_bib0004","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM198802113180602","article-title":"Liver disease and common-bile-duct stenosis in cystic fibrosis","volume":"318","author":"Gaskin","year":"1988","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jcf.2020.05.002_bib0005","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/adc.66.6.698","article-title":"Prevalence of liver disease in cystic fibrosis","volume":"66","author":"Scott-Jupp","year":"1991","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.1016\/j.jcf.2020.05.002_bib0006","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0022-3476(94)70361-2","article-title":"Analysis of risk factors for the development of liver disease associated with cystic fibrosis","volume":"124","author":"Colombo","year":"1994","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.jcf.2020.05.002_bib0007","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/adc.81.2.129","article-title":"The evolution of liver disease in cystic fibrosis","volume":"81","author":"Ling","year":"1999","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.jcf.2020.05.002_bib0008","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.510300527","article-title":"Natural history of liver disease in cystic fibrosis","volume":"30","author":"Lindblad","year":"1999","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jcf.2020.05.002_bib0009","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jhep.2004.08.006","article-title":"Epidemiology of liver disease in cystic fibrosis: a longitudinal study","volume":"41","author":"Lamireau","year":"2004","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jcf.2020.05.002_bib0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.prrv.2012.03.005","article-title":"Cystic fibrosis: what to expect now in the early adult years","volume":"13","author":"Quon","year":"2012","journal-title":"Paediatr Respir Rev"},{"issue":"2","key":"10.1016\/j.jcf.2020.05.002_bib0011","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1753465810386051","article-title":"Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population","volume":"5","author":"Parkins","year":"2011","journal-title":"Ther Adv Respir Dis"},{"issue":"1","key":"10.1016\/j.jcf.2020.05.002_bib0012","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/MPG.0000000000001728","article-title":"Variceal hemorrhage and adverse liver outcomes in patients with cystic fibrosis cirrhosis","volume":"66","author":"Ye","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.jcf.2020.05.002_bib0013","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/hep.30148","article-title":"Cystic fibrosis liver disease: outcomes and risk factors in a large cohort of French patients","volume":"69","author":"Bo\u00eblle","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jcf.2020.05.002_bib0014","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/MPG.0000000000001676","article-title":"Cystic fibrosis\u2013related liver disease","volume":"65","author":"Debray","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2020.05.002_bib0015","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease","volume":"10","author":"Debray","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2020.05.002_bib0016","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1203\/00006450-199809000-00023","article-title":"Transforming growth factor-\u03b21 in plasma and liver of children with liver disease","volume":"44","author":"Rosensweig","year":"1998","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1016\/j.jcf.2020.05.002_bib0017","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00005176-200308000-00019","article-title":"Plasma markers of platelet activation in cystic fibrosis liver and lung disease","volume":"37","author":"Schwarz","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.jcf.2020.05.002_bib0018","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3345\/kjp.2013.56.1.19","article-title":"The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice","volume":"56","author":"Kim","year":"2013","journal-title":"Korean J Pediatr"},{"issue":"4","key":"10.1016\/j.jcf.2020.05.002_bib0019","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1478-3231.2008.01675.x","article-title":"Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus\/hepatitis C virus co-infection","volume":"28","author":"Carvalho-Filho","year":"2008","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.jcf.2020.05.002_bib0020","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jpedsurg.2012.10.010","article-title":"Aspartate Aminotransferase-to-Platelet Ratio index (APRi) in infants with biliary atresia: prognostic value at presentation","volume":"48","author":"Grieve","year":"2013","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jcf.2020.05.002_bib0021","article-title":"Liver ultrasound patterns in children with cystic fibrosis correlate with non-invasive tests of liver disease","volume":"1","author":"Ling","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.jcf.2020.05.002_bib0022","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/hep.28016","article-title":"Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease","volume":"62","author":"Leung","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jcf.2020.05.002_bib0023","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/hep.30156","article-title":"MicroRNA sequencing identifies a serum microRNA panel, which combined with aspartate aminotransferase to platelet ratio index can detect and monitor liver disease in pediatric cystic fibrosis","volume":"68","author":"Calvopina","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jcf.2020.05.002_bib0024","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jcf.2020.05.002_bib0025","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.jcf.2020.05.002_bib0026","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/gutjnl-2015-309260","article-title":"The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa","volume":"65","author":"Lemoine","year":"2016","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.jcf.2020.05.002_bib0027","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MOG.0b013e3283298865","article-title":"Hepatobiliary disease in patients with cystic fibrosis","volume":"25","author":"Moyer","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"10.1016\/j.jcf.2020.05.002_bib0028","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1399-3046.2012.01652.x","article-title":"Portal hypertension in children: expert pediatric opinion on the report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"16","author":"Shneider","year":"2012","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.jcf.2020.05.002_bib0029","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1067\/msy.1999.98925","article-title":"Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition","volume":"126","author":"Chan","year":"1999","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.jcf.2020.05.002_bib0030","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archinte.163.2.218","article-title":"Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease","volume":"163","author":"Giannini","year":"2003","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.jcf.2020.05.002_bib0031","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1572-0241.1998.044_c.x","article-title":"AST\/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection","volume":"93","author":"Sheth","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.jcf.2020.05.002_bib0032","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1080\/00365520802158614","article-title":"ASAT\/ALAT ratio provides prognostic information independently of Child-Pugh class, gender and age in non-alcoholic cirrhosis","volume":"43","author":"Haukeland","year":"2008","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"10.1016\/j.jcf.2020.05.002_bib0033","doi-asserted-by":"crossref","first-page":"e51165","DOI":"10.1371\/journal.pone.0051165","article-title":"Serum \u03b3-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases. Ahn S-H, ed","volume":"7","author":"Petta","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jcf.2020.05.002_bib0034","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcf.2016.08.002","article-title":"Prevalence of elevated liver enzymes in children with cystic fibrosis diagnosed by newborn screen","volume":"16","author":"Woodruff","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2020.05.002_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPG.0000000000000758","article-title":"Increase of serum Gamma Glutamyltransferase (GGT) associated with the development of cirrhotic cystic fibrosis liver disease","volume":"61","author":"Bodewes","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2020.05.002_bib0036","doi-asserted-by":"crossref","DOI":"10.1097\/MPG.0000000000002412","article-title":"New algorithm for the integration of ultrasound into cystic fibrosis liver disease screening","author":"Sellers","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2020.05.002_bib0037","doi-asserted-by":"crossref","DOI":"10.1111\/hepr.13400","article-title":"Comparison of non\u2010invasive liver reserve and fibrosis models: Implications for surgery and prognosis for hepatocellular carcinoma","author":"Sonohara","year":"2019","journal-title":"Hepatol Res"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199320301338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199320301338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T21:13:45Z","timestamp":1593033225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199320301338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1569199320301338"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2020.05.002","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2020.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}